NRXP - NRX Pharmaceuticals, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
NRX Pharmaceuticals, Inc. Common Stock
IPO Date: May 5, 2021
Market Cap: $143.74M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.21 | 5.73%
Avg Daily Range (30 D): $0.10 | 3.01%
Avg Daily Range (90 D): $0.16 | 4.36%
Institutional Daily Volume
Avg Daily Volume: 1.15M
Avg Daily Volume (30 D): .9M
Avg Daily Volume (90 D): 1.06M
Trade Size
Avg Trade Size (Sh.): 222
Avg Trade Size (Sh.) (30 D): 148
Avg Trade Size (Sh.) (90 D): 154
Institutional Trades
Total Institutional Trades: 48
Avg Institutional Trade: $1.45M
Avg Institutional Trade (30 D): $1.57M
Avg Institutional Trade (90 D): $.86M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.6M
Avg Closing Trade (30 D): $1.57M
Avg Closing Trade (90 D): $.86M
Avg Closing Volume: 192.54K
 
News
Sep 8, 2026 @ 11:00 AM
NRx Pharmaceuticals to Participate in Upcoming Inv...
Source: Nrx Pharmaceuticals, Inc.
Jun 3, 2026 @ 12:18 PM
NRx Pharmaceuticals, Inc. Announces Pricing of Pub...
Source: Nrx Pharmaceuticals, Inc.
Jun 3, 2026 @ 5:46 AM
NRx Pharmaceuticals (NRXP) Stock Fell 19% After Ho...
Source: Tanya Rawat
May 20, 2026 @ 3:15 PM
My Top 3 Biotech Stocks for May 2026
Source: Jeff Siegel
May 18, 2026 @ 11:00 AM
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Qu...
Source: Nrx Pharmaceuticals, Inc.
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.44 $-.04 $.2
Diluted EPS
Revenue $1.1M $1.07M $.98M
Gross Profit $.43M $.44M $.58M
Net Income / Loss $-16.52M $-1.43M $.36M
Operating Income / Loss $-6.51M $-4.74M $-4.62M
Cost of Revenue $.68M $.63M $.41M
Net Cash Flow $19.97M $-1.08M $.61M
PE Ratio    
Splits
Apr 02, 2024 1:10